June 27th, 2008
UroToday.com - In the online version or Urologic Oncology, Dr. Andreas Hinz and associates from Germany report on a longitudinal study to assess psychological distress in cancer patients. They sought to investigate the impact of the cancer, side effects related to treatment of the cancer and patient anxiety regarding possible cancer recurrence.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 27th, 2008
NEW YORK (Reuters Health) Jun 19 - Acyclovir treatment does not reduce the incidence of HIV-1 infection in sexually active individuals who are seropositive for herpes simplex virus 2 (HSV-2), according to results of a multinational clinical trial reported in the June 21st issue of The Lancet.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 27th, 2008
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that a Phase 1 clinical trial of IMC-A12, ImClone’s fully human, IgG1 anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, plus the mTOR inhibitor temsirolimus in patients with advanced solid malignancies and lymphoma has opened for patient enrollment.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 27th, 2008
June 19, 2008 — Physicians treating people who are HIV positive still underestimate the increased risk of cardiovascular disease in this group, according to a group of HIV and CVD experts who participated in a joint conference in June 2007, organized by the American Heart Association and the American Academy of HIV Medicine.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 27th, 2008
BSD Medical Corp. (NASDAQ:BSDM) announced that another BSD-2000 hyperthermia system has been purchased, installed and is now in use in China, at the Liaocheng Peoples Hospital located in Liaocheng City, in the Western Shandong Province of the People’s Republic of China.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 27th, 2008
The European Medicines Agency (EMEA) has recommended updating the product information for epoetin-containing medicines with a new warning for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia in patients suffering cancer.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 26th, 2008
Men with prostate cancer caused by a faulty BRCA2 gene are more than twice as likely to die from the disease than those carrying the faulty BRCA1 gene - reveals a study published in the British Journal of Cancer*.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 26th, 2008
Bladder cancer survivors and caregivers will be celebrating the 4th of July with a renewed spirit and new purpose this year. They have banded together to raise awareness of this forgotten cancer, and will officially launch the American Bladder Cancer Society (ABLCS). Reminding Americans that bladder cancer now has a group of dedicated champions throughout the country fighting to save lives, finding a cure, and creating awareness.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 26th, 2008
Children and adolescents living with HIV have higher rates of risk factors for cardiovascular issues than HIV-negative children and adolescents, according to a study published in the June issue of the Journal of Pediatrics, the Miami Herald reports. In addition, many antiretroviral drugs can increase cardiovascular risk factors, the Herald reports.
Read the rest of this entry »
Posted in Uncategorized | No Comments »
June 26th, 2008
europacolon has called on all governments to implement existing EU recommendations on colorectal cancer screening following a new report published that shows the disease to be significantly neglected despite being the second most common cancer in Europe.1
Read the rest of this entry »
Posted in Uncategorized | No Comments »